Sense Biodetection
Sherlock Biosciences is pioneering advancements in molecular diagnostics by leveraging CRISPR and synthetic biology technologies. The company's proprietary platforms, such as the CRISPR-based SHERLOCK™ and synthetic biology-based INSPECTR™, are designed to enable rapid, accurate, and affordable DNA and RNA detection. These tools are meant for diverse settings, from clinical laboratories to point-of-need locations, promoting the decentralization and democratization of healthcare. Sherlock Biosciences is committed to revolutionizing healthcare by providing consumers with the ability to make informed health decisions through accessible diagnostic tests. The team comprises experts with extensive experience in CRISPR and Synthetic Biology, driving innovations that aim to disrupt traditional healthcare paradigms and enhance global health outcomes.
Company details
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Medical Monitoring
- Market Focus:
- Globally (various continents)
About Us
At Sense, we believe that if you can test anywhere, you can change everything. We’re focused on creating unconstrained, instrument-free molecular diagnostic technologies that allow caregivers to open the care pathway to everyone – in a way that’s nothing short of revolutionary.
Making quality care more accessible to all
Our diagnostic technologies deliver incredibly fast, accurate results, are easy for clinicians to master, and offer the flexibility to run one test or dozens at the same time. So testing can be performed almost anywhere* by anyone, and caregivers are able to reduce overall costs while driving more efficient care.
Approach
In a world that’s changing fast, realizing the full potential of molecular point-of-care diagnostics requires a new approach – one that meets the actual needs of front-line caregivers.
While competitors simply re-imagine the same old instrument-centric model, Sense has developed entirely new methods that make it possible to create fast, easy-to-use, instrument-free handheld tests with the power of advanced laboratory instruments.
Design
As healthcare evolves, there’s a growing expectation for diagnostic tests to be performed wherever they are needed by end-users*, rather than in the central lab. Designing products that meet those needs starts with understanding our users and their environments in detail.
That’s why Sense takes a user-centered approach to design, ensuring that simplicity and usability are always our top focus. We develop the technologies required to create the ideal product, rather than develop compromised products to suit the available technologies.
Technology
We’ve designed a suite of proprietary molecular amplification and device technologies from the ground up, specifically for integration into our handheld, instrument-free, single use product.
Our molecular methods offer an easy-to-use and ultra-rapid alternative to polymerase chain reaction (PCR), enabling sensitive detection of specific nucleic acids without the need for complex hardware. Plus, Sense devices include innovations in low-cost fluid handling, temperature control, visual read advancements, and electromechanical design. These technologies allow caregivers to receive conclusive, PCR-quality results within 15 minutes, so treatment decisions can be made immediately.